TABLE 2.
Votes on Other Benefits and Contextual Considerations for Tirzepatide
| When making judgments of overall long-term value for money, what is the relative priority that should be given to any effective treatment for T2DM on the basis of the following contextual considerations? | |||||
|---|---|---|---|---|---|
| Contextual consideration | Very low priority | Low priority | Average priority | High priority | Very high priority |
| Acuity of need for treatment of individual patients based on short-term risk of death or progression to permanent disability | 2 | 2 | 7 | 1 | 1 |
| Magnitude of the lifetime impact on individual patients of the condition being treated | 0 | 0 | 3 | 6 | 4 |
| What are the relative effects of tirzepatide added to background therapy vs injectable semaglutide (Ozempic) added to background therapy on the following outcomes that inform judgment of the overall long-term value for money of tirzepatide? | |||||
| Potential other benefit or disadvantage | Major negative effect | Minor negative effect | No difference | Minor positive effect | Major positive effect |
| Patients’ ability to achieve major life goals related to education, work, or family life | 0 | 0 | 7 | 6 | 0 |
| Caregivers’ quality of life and/or ability to achieve major life goals related to education, work, or family life | 0 | 0 | 9 | 4 | 0 |
| Society’s goal of reducing health inequities | 0 | 0 | 13 | 0 | 0 |